Posted in: Quality Testing, Buyer Resources
GHK-Cu EVIDENCE REVIEW
Copper Tripeptide-1 is one of skincare’s most recognizable peptides. But a fluorescent signal in pig skin, a pigmentation change in zebrafish and a result from a finished essence answer three very different questions. Here is what the research can support—and what formulators should test next.

The most useful question is not whether GHK-Cu has a promising study. It is what was tested, how the result was measured, and how closely that setup matches the product or claim you are evaluating. The available dossier moves from an ex vivo skin model and a zebrafish screen to cell assays and a finished-essence use test. Read as an evidence ladder, it offers more insight than a single headline percentage.
What the evidence package contains
- Skin model: 0.1% FITC-labelled Copper Tripeptide-1 on excised pig skin in Franz diffusion cells, observed from 0 to 24 hours.
- Zebrafish screen: a 0.1% test concentration, with pigmentation signal measured after 45 hours.
- Cell studies: fibroblast, photo-stress and chemical antioxidant assays that generate hypotheses for further testing.
- Finished essence: a 28-day split-face comparison against a matching blank, with 32 participants completing the test.
One peptide, four levels of evidence
These studies are not interchangeable. An ex vivo model can show where a labelled signal appears in excised tissue. A zebrafish assay can screen a biological response in a developing organism. Cell assays isolate selected mechanisms under controlled conditions. A human-use test evaluates a finished formula as used by participants. Each step answers a different question; none should be promoted as though it were the next step up the ladder.
1. Pig-skin diffusion: a time-dependent signal, not proof of human delivery
The supplied 2021 report used one-month-old pig back skin mounted in Franz diffusion cells. The test sample was 0.1% FITC-labelled Copper Tripeptide-1. Researchers collected skin at 0, 2, 4, 6 and 24 hours, with three repeats per time point, and examined fluorescent signal in skin sections. The report found a significant increase in measured fluorescence at each successive time point. The report identifies the test sample and its supplier; the result should be read as evidence about that submitted sample and protocol.

This is a useful model signal: fluorescence associated with the labelled test material was detected in the excised-skin system, and the signal changed over time. It is not a measurement of intact, unlabelled GHK-Cu reaching a defined layer of living human skin. The fluorescent tag, tissue model, formulation vehicle, dose and analytical method all affect what the result means.
That distinction is reinforced by recent peer-reviewed work on liposomal GHK-Cu. Researchers have examined how formulation carriers and analytical methods affect permeation measurements, highlighting that peptide delivery is a measurement problem as well as a formulation problem. For product development, the practical takeaway is to test the intended formula and use a method that can distinguish the peptide or copper complex of interest from its label or carrier.
2. Zebrafish pigmentation: an assay signal, not a human skin-tone result
A 2022 zebrafish report evaluated Copper Tripeptide-1 at 0.1%. The assay used early-stage AB-strain zebrafish, measured head pigmentation after 45 hours, and analyzed 10 fish per group. The report classified the test sample as effective under its stated assay method and statistical criteria.

The endpoint was pigment signal in a zebrafish screening model. It does not predict a percentage change in human skin tone or establish the performance of a finished brightening cosmetic. It can help researchers decide whether a hypothesis merits testing in a more relevant model, with a suitable finished formula and human-relevant endpoint.
3. Fibroblast assays: mechanism clues with a model boundary
The supplied in vitro package includes a fibroblast anti-wrinkle assay, cell-proliferation measurements and DPPH/PTIO radical-scavenging assays. In a UVA-induced fibroblast condition, one report measured lower MMP-1 expression at increasing test concentrations; another condition reported higher COL1 protein expression at selected concentrations. Separate chemical assays measured radical-scavenging activity under their stated laboratory conditions.
Those results describe cells or a chemical assay under specified laboratory conditions. They can guide a research question about photo-stress, extracellular-matrix markers or antioxidant activity. They do not demonstrate that a consumer’s skin will show the same biomarker change, nor do the assay concentrations establish an appropriate level for a face serum. A formulation team should use these findings to design the next experiment, not to skip it.

4. The 28-day split-face test: the most consumer-relevant result in this package
The supplied 2025 report tested two finished products: a blue copper-peptide essence and a matching blank essence. Thirty-two adults (26 women and 6 men, ages 22–59) completed a 28-day split-face routine, applying the test essence to one side and the blank to the other morning and evening. Measurements were taken at baseline, day 14 and day 28. The protocol included corneometer hydration readings, visual wrinkle grading, 3D skin imaging and cutometer elasticity measurements.

The report describes statistically significant differences versus the matching blank on several hydration, wrinkle and elasticity measures at day 28. It also records an important exception: the day-14 crow’s-feet wrinkle-grade comparison was not statistically significant, while the day-28 comparison was. That detail makes the evidence more informative, not less: it shows why time points and individual endpoints should be read from the full protocol rather than compressed into a single broad claim.
The test belongs to the specific finished essence, its blank comparator, participants and study conditions. It identifies Shandong Jitai Biotechnology Co., Ltd. as the commissioning organization. It cannot isolate Copper Tripeptide-1 from every other formula variable or establish that another formula or raw-material lot will produce the same outcome. The report also states restrictions on partial reproduction and promotional use; detailed tables or report images should only be reproduced with the testing institution’s written approval.
What the wider literature adds: delivery is still the hard question
A 2024 review of topical GHK described encouraging cell research but limited published evidence for topical GHK-Cu performance in people at that time. The supplied 2025 split-face report adds a defined human-use test of one finished essence, but it does not turn the broader literature into a large body of independent clinical trials. That timeline is useful: one product study is a meaningful data point, while replication and formula-specific evidence still matter.
A 2023 Pharmaceutics study formulated GHK-Cu in liposomes and measured carrier properties and in vitro enzyme assays. In that specific laboratory system, the authors reported no significant effect on tyrosinase activity and an elastase-inhibition signal. These are formulation and in vitro findings, not clinical brightening or wrinkle outcomes.
A 2025 Molecules review then focused on how to measure skin transport of free and liposome-encapsulated GHK-Cu. It describes limited research on GHK-Cu liposome transport and calls for better methods to assess how carriers affect transport and trafficking. Together, these papers sharpen the formulation questions: Is the peptide compatible with the vehicle? Does the analytical method track the relevant species? Is the carrier part of the tested system? Does the finished formula retain its intended properties through processing, packaging and storage?
How to turn these findings into a credible development plan
- Start with identity and documents. Confirm the INCI name, material form, current specification, test methods and lot-specific COA for the ingredient being evaluated.
- Choose the question before the test. Use a permeation model for a delivery question, a cell assay for a mechanism question, and a finished-product study for a product-performance question.
- Test the intended formula. Record concentration, pH, process, packaging, controls, time points and acceptance criteria. Check appearance and stability in the actual system.
- Match claim language to evidence. A model result supports a model-level statement. Finished-product claims need evidence that matches the formula, endpoint, use conditions and target market.
Research sources and study context
- Ogórek K, et al. “Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?” Molecules (2025). doi:10.3390/molecules30010136.
- Dymek M, et al. “Liposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Application.” Pharmaceutics (2023). doi:10.3390/pharmaceutics15102485.
- Mortazavi SM, et al. “Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective.” BioImpacts (2024). doi:10.34172/bi.30071.
- Jiang F, et al. “Synergy of GHK-Cu and hyaluronic acid on collagen IV upregulation via fibroblast and ex-vivo skin tests.” Journal of Cosmetic Dermatology (2023). doi:10.1111/jocd.15763.
- Supplied ex vivo skin report: Franz diffusion-cell pig-skin model, 0.1% FITC-labelled sample, 2021; report 2112070.
- Supplied zebrafish report: early-stage pigmentation assay, 0.1% sample, 2022; project 5226-1.
- Supplied human-use report: 28-day split-face test of a finished essence and matching blank, 32 completers; report SEC25052043, issued July 14, 2025.
Study observations are limited to the samples, methods, endpoints and conditions described in the cited publications and reports. They should not be read as batch-specific efficacy data or as proof that every Copper Tripeptide-1 formula will perform the same way. The product photograph is a product reference image; it does not depict the laboratory samples or imply that those tests were run on the pictured lot.
Explore Copper Tripeptide-1 for your formulation
Visit the Copper Tripeptide-1 (GHK-Cu) product page for product information and B2B inquiry options. For documentation or a quotation, contact david.z@goodnutrition-bio.com with your target application and destination market.





